IL96149A - Processes for the preparation of N-) 2-hydroxymethyl-3,4,5-trihydroxypipridines - Google Patents

Processes for the preparation of N-) 2-hydroxymethyl-3,4,5-trihydroxypipridines

Info

Publication number
IL96149A
IL96149A IL9614990A IL9614990A IL96149A IL 96149 A IL96149 A IL 96149A IL 9614990 A IL9614990 A IL 9614990A IL 9614990 A IL9614990 A IL 9614990A IL 96149 A IL96149 A IL 96149A
Authority
IL
Israel
Prior art keywords
reaction
compounds
formula
solution
aqueous
Prior art date
Application number
IL9614990A
Other languages
English (en)
Hebrew (he)
Other versions
IL96149A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL96149A0 publication Critical patent/IL96149A0/xx
Publication of IL96149A publication Critical patent/IL96149A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Enzymes And Modification Thereof (AREA)
IL9614990A 1989-11-01 1990-10-29 Processes for the preparation of N-) 2-hydroxymethyl-3,4,5-trihydroxypipridines IL96149A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3936295A DE3936295A1 (de) 1989-11-01 1989-11-01 Verfahren zur herstellung von zwischenprodukten und zur synthese von n-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine

Publications (2)

Publication Number Publication Date
IL96149A0 IL96149A0 (en) 1991-07-18
IL96149A true IL96149A (en) 1995-05-26

Family

ID=6392610

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9614990A IL96149A (en) 1989-11-01 1990-10-29 Processes for the preparation of N-) 2-hydroxymethyl-3,4,5-trihydroxypipridines

Country Status (16)

Country Link
US (1) US5071990A (da)
EP (1) EP0425929B1 (da)
JP (1) JP2858927B2 (da)
KR (1) KR0169977B1 (da)
AT (1) ATE131155T1 (da)
CA (1) CA2028909C (da)
DE (2) DE3936295A1 (da)
DK (1) DK0425929T3 (da)
ES (1) ES2082815T3 (da)
FI (1) FI93443C (da)
GR (1) GR3018765T3 (da)
HU (1) HU205946B (da)
IE (1) IE70059B1 (da)
IL (1) IL96149A (da)
PT (1) PT95737B (da)
ZA (1) ZA908723B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
WO2006133448A1 (en) * 2005-06-08 2006-12-14 Amicus Therapeutics, Inc. Stabilization of triflated compounds
BRPI0613222A2 (pt) * 2005-06-08 2010-12-28 Amicus Therapeutic Inc método para purificação de um açúcar bruto contendo nitrogênio e método para purificar d-l-deoxigalactonojirimicina bruta (dgj)
CN101228174A (zh) * 2005-06-08 2008-07-23 阿米库斯治疗学公司 晶体糖组合物及其制备方法
CN103980290B (zh) * 2013-12-06 2016-08-17 华东理工大学 具有杀虫活性的吗啉并环类化合物、及其制备和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759929A (en) * 1970-11-02 1973-09-18 Basf Ag Manufacture of {62 -hydroxy carbonyl compounds and/or {60 -unsaturated carbonyl compounds
DE2758025A1 (de) * 1977-12-24 1979-07-12 Bayer Ag Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
DE2922760A1 (de) * 1979-06-05 1980-12-11 Bayer Ag Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
JPS6011902B2 (ja) * 1979-12-27 1985-03-28 日本新薬株式会社 モラノリンの誘導体
DE3024901A1 (de) * 1980-07-01 1982-01-28 Bayer Ag, 5090 Leverkusen Herbizide mittel auf basis von piperidin-derivaten
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3049446A1 (de) * 1980-12-30 1982-07-29 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,5-didesoxy-1,5-imino-d-glucitol und dessen n-derivaten
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
JPS62267292A (ja) * 1986-05-14 1987-11-19 Nippon Shinyaku Co Ltd モラノリン誘導体の製法
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
EP0344383A1 (en) * 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Novel alpha-Glucosidase inhibitors
DE3906463A1 (de) * 1989-03-01 1990-09-06 Bayer Ag Verfahren zur herstellung von n-hydroxyalkyl-substituierten derivaten von 3,4,5-trihydroxypiperidinen

Also Published As

Publication number Publication date
FI905353A0 (fi) 1990-10-30
FI93443B (fi) 1994-12-30
HUT55404A (en) 1991-05-28
CA2028909C (en) 2002-01-22
ZA908723B (en) 1991-08-28
KR0169977B1 (ko) 1999-02-18
EP0425929A1 (de) 1991-05-08
HU205946B (en) 1992-07-28
DE59009951D1 (de) 1996-01-18
US5071990A (en) 1991-12-10
CA2028909A1 (en) 1991-05-02
IE70059B1 (en) 1996-10-16
JPH03153666A (ja) 1991-07-01
EP0425929B1 (de) 1995-12-06
ES2082815T3 (es) 1996-04-01
JP2858927B2 (ja) 1999-02-17
PT95737B (pt) 1997-11-28
DE3936295A1 (de) 1991-05-02
IL96149A0 (en) 1991-07-18
ATE131155T1 (de) 1995-12-15
FI93443C (fi) 1995-04-10
IE903924A1 (en) 1991-05-08
GR3018765T3 (en) 1996-04-30
DK0425929T3 (da) 1996-04-15
PT95737A (pt) 1991-09-13
KR910009661A (ko) 1991-06-28

Similar Documents

Publication Publication Date Title
US4806650A (en) Process for preparing 1-deoxynojirimycin and N-derivatives thereof
CA1113100A (en) Preparation of 1-desoxy-nojirimicin and n-substituted derivatives
KR20050107796A (ko) 1,2-다이아미노 화합물을 제조하기 위한 아자이드 비함유공정
FURUKAWA et al. Asymmetric syntheses of β-amino acids by the reduction of enamines
US5071990A (en) Preparation of intermediates and the synthesis of n-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidines
AU717720B2 (en) Process for preparing 1,4,7,10-tetraazacyclododecane and its derivatives
CA2299364A1 (en) Process for the preparation of l-ascorbic acid
KR20060122464A (ko) 신규 탈할로겐화제를 이용한 슈도-아미노슈가의 제조방법
US4879393A (en) 4-Benzyloxy-3-pyrrolin-2-on-1-yl acetamide production
EP1575952B1 (en) Synthesis of heteroaryl acetamides
RU1817776C (ru) Способ получени (4-амино-2,6-диметилфенилсульфонил)нитрометана
Viallon et al. Thermal and acid-catalysed sigmatropic rearrangements of allylamino-methoxy-1, 2-benzoquinones
Petruš et al. Reduction of glycosylnitromethanes to glycosylmethylamines with ferrous salts
CN114213323B (zh) 一种盐酸丙卡特罗的合成新工艺
EP0359263B1 (en) Synthesis of intermediate useful in the preparation of nojirimycin and related compounds
Moskalenko et al. Synthesis of N-arylmethyl-3-azabicyclo [3.3. 1] nonan-9-ones.
CN115785089A (zh) 一种利奥西呱杂质c的合成方法
SU1366517A1 (ru) Способ получени 3-( @ -D-глюкопиранозил)-4-оксигексагидропиримидин-2-тиона
EP1272493B1 (en) A process for the preparation of decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene and functionalized derivatives
CN117820241A (zh) 伊曲茶碱中间体的制备方法
KR820001122B1 (ko) N-알케닐 몰라노린 유도체의 제조방법
KR830000752B1 (ko) 치환 헤테로싸이클 n-알칸올아민의 제조방법
HU196964B (en) Process for producing amino-nitro-pyridine derivatives
KR20050051612A (ko) 감마-아미노레불리닉 엑시드 염산염의 신규한 제조 방법
US20100256358A1 (en) Process for Preparing 4-Acetyl-2,3,4,5-tetrahydro-benzo[1,4]diazepine and the Intermediates Thereof

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
FF Patent granted
EXP Patent expired